Antonio A. Castillo-Garcia, Jörg Haupenthal, Anna K. H. Hirsch and Katalin Barta
{"title":"木质素衍生愈创木酚作为平台化学品模块化合成1,2,3,4-四氢喹啉和苯并噻吩啉。","authors":"Antonio A. Castillo-Garcia, Jörg Haupenthal, Anna K. H. Hirsch and Katalin Barta","doi":"10.1039/D5SU00151J","DOIUrl":null,"url":null,"abstract":"<p >Reductive catalytic fractionation (RCF) has emerged as a centrally important method in modern biorefining, delivering well-defined aromatic platform chemicals from lignin with high selectivity. To establish attractive future biorefinery schemes, urgent attention needs to be devoted to the development of sustainable catalytic methods for the downstream conversion of these aromatic platform chemicals. In this regard, the efficient production of structurally complex, biologically active amines with high atom and step economy represents an attractive goal. Herein, we describe the development of novel catalytic pathways for converting prominent lignin-derived guaiacols that originated during RCF processing into different series of six-membered N-heterocycles, applying hydrogen borrowing amination and C–N cross coupling as key catalytic steps. Specifically, 4-propanol guaiacol (<strong>1G</strong>) was converted into 1,2,3,4-tetrahydroquinolines <strong>1Gd<small><sub>n</sub></small></strong>, whereas the formation of benzomorpholines <strong>2–3Gd<small><sub>n</sub></small></strong> from 4-propyl guaiacol (<strong>2G</strong>) and 4-ethyl guaiacol (<strong>3G</strong>) was achieved. The biological activity of the developed compound libraries was evaluated in terms of anticancer activity using human HepG2 cells, which displayed promising activity in several examples.</p>","PeriodicalId":74745,"journal":{"name":"RSC sustainability","volume":" 9","pages":" 4039-4048"},"PeriodicalIF":4.9000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12264585/pdf/","citationCount":"0","resultStr":"{\"title\":\"Lignin-derived guaiacols as platform chemicals for the modular synthesis of 1,2,3,4-tetrahydroquinolines and benzomorpholines†\",\"authors\":\"Antonio A. Castillo-Garcia, Jörg Haupenthal, Anna K. H. Hirsch and Katalin Barta\",\"doi\":\"10.1039/D5SU00151J\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Reductive catalytic fractionation (RCF) has emerged as a centrally important method in modern biorefining, delivering well-defined aromatic platform chemicals from lignin with high selectivity. To establish attractive future biorefinery schemes, urgent attention needs to be devoted to the development of sustainable catalytic methods for the downstream conversion of these aromatic platform chemicals. In this regard, the efficient production of structurally complex, biologically active amines with high atom and step economy represents an attractive goal. Herein, we describe the development of novel catalytic pathways for converting prominent lignin-derived guaiacols that originated during RCF processing into different series of six-membered N-heterocycles, applying hydrogen borrowing amination and C–N cross coupling as key catalytic steps. Specifically, 4-propanol guaiacol (<strong>1G</strong>) was converted into 1,2,3,4-tetrahydroquinolines <strong>1Gd<small><sub>n</sub></small></strong>, whereas the formation of benzomorpholines <strong>2–3Gd<small><sub>n</sub></small></strong> from 4-propyl guaiacol (<strong>2G</strong>) and 4-ethyl guaiacol (<strong>3G</strong>) was achieved. The biological activity of the developed compound libraries was evaluated in terms of anticancer activity using human HepG2 cells, which displayed promising activity in several examples.</p>\",\"PeriodicalId\":74745,\"journal\":{\"name\":\"RSC sustainability\",\"volume\":\" 9\",\"pages\":\" 4039-4048\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12264585/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"RSC sustainability\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://pubs.rsc.org/en/content/articlelanding/2025/su/d5su00151j\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"RSC sustainability","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/su/d5su00151j","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Lignin-derived guaiacols as platform chemicals for the modular synthesis of 1,2,3,4-tetrahydroquinolines and benzomorpholines†
Reductive catalytic fractionation (RCF) has emerged as a centrally important method in modern biorefining, delivering well-defined aromatic platform chemicals from lignin with high selectivity. To establish attractive future biorefinery schemes, urgent attention needs to be devoted to the development of sustainable catalytic methods for the downstream conversion of these aromatic platform chemicals. In this regard, the efficient production of structurally complex, biologically active amines with high atom and step economy represents an attractive goal. Herein, we describe the development of novel catalytic pathways for converting prominent lignin-derived guaiacols that originated during RCF processing into different series of six-membered N-heterocycles, applying hydrogen borrowing amination and C–N cross coupling as key catalytic steps. Specifically, 4-propanol guaiacol (1G) was converted into 1,2,3,4-tetrahydroquinolines 1Gdn, whereas the formation of benzomorpholines 2–3Gdn from 4-propyl guaiacol (2G) and 4-ethyl guaiacol (3G) was achieved. The biological activity of the developed compound libraries was evaluated in terms of anticancer activity using human HepG2 cells, which displayed promising activity in several examples.